The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two or three is ending early due to robust positive evidence found in previous ...

Kerry Series’ dream of creating a Sydney-based Asian equities powerhouse will be more achievable in his newly-created role of AMP Capital Investors’ head of Asia-Pacific equities than it was in his ...

In a report released on January 30, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...

In close partnership with ALLIED Feather + Down (AF+D) and premium performance wear manufacturer Active Apparel Group, Templa ...

Red Car Trolley at Disney California Adventure will make non-stop trips between Buena Vista Street and Sunset Boulevard ...

The Celebrate Soulfully event honoring Black culture will run throughout February at Disneyland, Downtown Disney and the ...

Gates appeared before Tupelo Municipal Court Judge Jay Weir on January 30 and was ordered to be held without bond.

Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

California’s peak stomach flu season is expected to continue to April. Hand sanitizers don't kill the illness, which spreads ...

BlockFills, a digital assets technology and trading firm for institutions and professional traders, has announced a ...

12. “Don’t Believe Everything You Think (expanded ed.)” by Joseph Nguyen (Authors Equity) ...

A phase 3 trial evaluating sotatercept-csrk (Winrevair™) in adults with pulmonary arterial hypertension (PAH; World Health Organization Group 1) ...